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WITH ACUTE CORONARY INFLOW restriction, contractile function in the ischemic region is rapidly reduced, and after a few minutes, there is a consistent relation between reduced regional myocardial blood flow (RMBF) and reduced myocardial function (13, 14) , i.e., perfusion-contraction matching (23) which is maintained over several hours (22) and a hallmark of shortterm hibernation (15) . Coronary microembolization (ME) secondary to spontaneous (2, 7) or therapeutic (4, 24) plaque rupture occurs clinically and is of pathophysiological significance in acute coronary syndromes (5, 6, 11, 21, 26) . The relation of flow and function with coronary microvascular obstruction is not known. Therefore, we compared the effects of coronary ME with those of an epicardial coronary stenosis (STE) on RMBF and function in anesthetized dogs.
METHODS
The experimental protocol used in this study was approved by the bioethical committee of the district of Dü sseldorf, Germany.
Experimental preparation. Fifteen mongrel dogs (24-36 kg body wt) were anesthetized with an initial intravenous bolus of thiamylal sodium (15 mg/kg). After endotracheal intubation, anesthesia was maintained by ventilation using enflurane with an oxygen-nitrous oxide mixture. Left ventricular and aortic pressures were measured with catheter-tip manometers (PC 350; Millar, Houston, TX). For the measurement of RMBF, a Teflon catheter was placed into the left atrium for microspheres injection, and another Teflon catheter was inserted into the upper descending aorta for blood withdrawal. Ultrasonic crystals were implanted in the anterior left ventricular wall (control area) and in the posterolateral wall perfused by the left circumflex coronary artery (LCx) for measurement of regional myocardial wall thickness. A Teflon catheter was inserted into the left carotid artery to supply blood to the extracorporeal circuit. Anticoagulation was induced with 300 U/kg heparin sodium, and additional doses of 300 U/kg heparin sodium were given after 4 h. The LCx was cannulated proximal to its first branch and perfused from an extracorporeal circuit driven by a calibrated, occlusive roller-pump (Masterflex; Cole Parmer, Barrington, IL). Coronary arterial pressure was measured from the sidearm of the cannula.
Measurement of RMBF. Regional myocardial blood flow was determined with four different-colored (yellow, red, blue, violet) 15-m microspheres (20) . For each measurement, ϳ5 ϫ 10 6 to 10 ϫ 10 6 microspheres suspended in 6 ml of saline with 0.02% Tween 80 (Sigma) were injected into the left atrium followed by a flush of 6 ml of saline. The withdrawal of arterial reference blood samples was started 30 s before injection of the microspheres and continued for 150 s at a rate of 5.3 ml/min (model 901A; Harvard Apparatus, S. Natick, MA).
Experimental protocol. After stabilization, control measurements of systemic hemodynamics, RMBF, and function were made. Measurements were repeated after 1, 4, and 8 h.
Coronary ME. The perfusion pump was adjusted so that mean coronary arterial pressure was matched to mean aortic pressure throughout the protocol. After control measurements, 3,000 white-stained (20) microspheres (42 m Dynospheres; Dyno Particles, Lillestrøm, Norway) per milliliter per minute coronary inflow were injected into the cannulated LCx (n ϭ 6 dogs). The microspheres were made of polysterene cross-linked with 2% divinylbenzene and therefore were chemically inert and without a charge.
Epicardial coronary STE. After control measurements with mean coronary arterial pressure matched to mean aortic pressure, inflow to the LCx was continuously decreased to match posterior systolic wall thickening (PWT) to that of the ME group at 1, 4, and 8 h, respectively (n ϭ 6 dogs). After completion of the protocol, the area at risk was delineated by injection of white 15-m microspheres.
Sham group, n ϭ 3. Three dogs were subjected to 8 h of continuous pump perfusion and measurements were made at control and after 1, 4, and 8 h.
Postmortem analysis. The heart was removed and about 10 mm ϫ 10 mm transmural tissue specimens were taken from the ischemic and the control area near the site of the ultrasonic crystals and then fixed in 4% buffered formaldehyde. The heart was sectioned from base to apex into five slices in a plane parallel to the atrioventricular groove and immersed in a 0.09 M sodium phosphate buffer (pH 7.4) containing 1.0% 2,3,5-triphenyltetrazolium chloride (Sigma, Deisenhofen, Germany) and 8% dextran (mol wt, 77,800) for 20 min at 37°C to identify infarcted tissue. The left ventricle was then divided into subendocardial, midmyocardial, and subepicardial pieces of ϳ300 mg weight.
After tissue digestion and extraction of the dye, the color spectra of each myocardial and arterial reference withdrawal sample were measured with a spectrophotometer (model 8452A; Hewlett-Packard, Palo Alto, CA), as previously reported (20) . Only subendocardial and transmural blood flow and the subendocardium-to-subepicardium ratio (endo/epi) at the site of the ultrasonic crystals are reported. The area at risk was determined from the white 42-m microspheres in the ME group and from the white 15-m microspheres in the STE group (27) .
The transmural formaldehyde-fixed specimens were embedded in paraffin and sectioned into slices of 5 m thickness. Three such sections (total area 1.8 cm 2 ) each from the ischemic and the control area of each dog were stained with hematoxylin and eosin and examined using light microscopy at ϫ400 magnification (DMSL; Leica, Bernsheim, Germany). Tissue areas exhibiting hypereosinophilia, contraction bands, and thinning and waviness of fibers were appreciated as necrotic foci using a phase-contrast microscope connected to a video camera module (DC 100; Leica). The area of all necrotic foci was determined by planimetry (dhs Bilddatenbank V4.01; Leica) and expressed as percentage of the total area of all analyzed tissue sections.
In the same sections, inflammatory cells were counted in 50 fields of 190,000 m 2 each from the ischemic and the control area. The vast majority of inflammatory cells were polymorphonuclear leukocytes (PMN). In addition, a separate immunohistochemical analysis of mononuclear leukocytes was performed. For that, other tissue sections were dewaxed, rehydrated, rinsed with phosphate buffer saline (PBS), digested with freshly prepared proteinase K (50 g/ml 10 mM Tris buffer; Boehringer-Mannheim, Mannheim, Germany) for 5 min, rinsed again with PBS, and incubated with rabbit anti-human muramidase antibody (Dako A099; diluted 1:100; Glostrup, Denmark) overnight at room temperature. This antibody in pigs specifically stains macrophages/monocytes (1, 8) . A FITC-labeled anti-rabbit antibody (Dako F0205; diluted 1:100, 3 h exposure) was used as a detection system. In all specimens there was a dense infiltration in the immediate subepicardium (up to 1 mm depth) that was not included in the analysis. Excluding this subepicardial zone, the number of macrophages/monocytes was determined in a total area of 1.1 cm 2 each from the control and the ischemic zone using fluorescence microscopy at ϫ400 magnification.
Chemotaxis assay in vitro. Venous blood samples from three additional dogs were collected in sterile tubes containing preservative-free heparin. PMN and mononuclear cells (MN) were isolated by centrifugation on Ficoll-hypaque (1.077 g/ml; Lymphoprep; Nycomed, Oslo, Norway) at 400 g for 25 min. The MN at the interface were collected, washed in PBS and resuspended at 1.5 ϫ 10 6 cells/ml in Iscove's modified Dulbecco's medium (350 osmol/kg; IMDM; Life Technologies, Grand Island, NY) supplemented with 1% fetal calf serum (FCS; PAA Laboratories, Linz, Austria). The PMN collected below the interface were washed and resuspended similarly. To obtain medium with chemotactic activity, 5 ml of the MN suspension was incubated with 200 U/ml of recombinant human tumor necrosis factor-␣ (rhTNF-␣, R&D Systems, Wiesbaden, Germany) at 37°C in 5% CO 2 and removed using filters of 0.2 m pore size (Minisart, Sartorius, Göttin-gen, Germany) after 2 h. Units of rhTNF-␣ activity were calculated according to internal rhTNF-␣ standards (R&D Systems). Migration experiments were performed using filters of 5-m pore size in 6.5-mm transwell chambers (Costar, Cambridge, MA) with 5% CO 2 at 37°C (19) . Aliquots of the untreated PMN suspension (100 l) or the untreated MN suspension (100 l), respectively, were placed in the upper chamber of the transwells. The lower chamber contained either 600 l of TNF-␣-conditioned medium (as a positive control) or 600 l of IMDM plus 1% fetal calf serum (FCS) without (as a negative control) or with 42 m white microspheres (3 microspheres/l, corresponding to the average number of 42 m spheres in 1 mg of myocardium). After the cells were placed in incubation for 8 h at 37°C in 5% CO 2 , a hemocytometer was used to count the cells as they migrated into the lower chamber in duplicate assays. The number of cells in the lower chamber are presented as a percentage of those in the upper chamber.
Data analysis and statistics. Systemic hemodynamics and regional myocardial wall thickness were continuously monitored on an eight-channel forced-ink chart recorder (MK 200 A; Gould, Cleveland, OH) and stored directly to the hard disk of a computer. Hemodynamic and functional parameters were digitized and recorded over a 20-s period for each intervention (25) .
Data are reported as mean values Ϯ SD. Infarct size in both groups was compared by unpaired t-tests. The number of leukocytes in the control and the ischemic area in both groups was compared by two-way ANOVA. Changes in hemodynamics, RMBF, and function were estimated by twoway ANOVA for repeated measures. When a significant overall effect was detected, Fisher's least significant difference tests were performed to compare single mean values. Linear regression analysis was performed to evaluate the relationship between posterior subendocardial (PSBF) and posterior transmural blood flow (PTBF), respectively, and systolic wall thickening, as previously described by Gallagher et al. (13) . Posterior blood flow data were normalized as fractions of anterior blood flow; systolic wall thickening data were normalized as fractions of their control values (13) . A P value Ͻ 0.05 was taken to indicate a significant difference.
RESULTS
In the sham group, systemic hemodynamics as well as RMBF and function remained constant throughout the 8-h continuous perfusion period. There was neither macroscopic nor microscopic evidence for myocardial infarction, and there was no inflammatory response.
Chemotaxis assay in vitro. The 42-m white microspheres were without chemotactic activity on PMN (40.9 Ϯ 3.8 vs. 44.2 Ϯ 3.2% in the negative and 65.4 Ϯ 3.0% in the positive controls, respectively) as well as on MN (3.0 Ϯ 0.5 vs. 2.6 Ϯ 1.2% in the negative and 19.6 Ϯ 3.7% in the positive controls, respectively).
Hemodynamics. Heart rate, left ventricular peak pressure, first derivative of pressure development over time (dP/dt), and mean aortic pressure remained unchanged throughout the protocol in both the ME and the STE group and, except for dP/dt at control, were not different among groups. Left ventricular end-diastolic pressure was increased in both groups at 8 h. In the ME group, coronary blood flow was unaltered, whereas it was progressively reduced in the STE group (Table 1) .
Regional myocardial blood flow and function. Anterior systolic wall thickening remained constant throughout the protocol, whereas PWT was decreased progressively to a similar extent in both groups (Table  2) . Anterior subendocardial and transmural blood flow were unaltered at 1 and 4 h in both groups, but increased at 8 h. In the ME group, PSBF and PTBF were also not changed at 1 and 4 h, but increased at 8 h. In contrast, PSBF and PTBF were progressively decreased in the STE group (Table 2) .
In the STE group, there was a close relationship between normalized, both subendocardial and transmural, myocardial blood flow, respectively, and function. In contrast in the ME group, regional function was progressively decreased, with no reduction of subendocardial and transmural blood flow (Fig. 1) . Values are means Ϯ SD. AWT, anterior systolic wall thickening; PWT, posterior systolic wall thickening; ASBF, anterior subendocardial blood flow; ATBF, anterior transmural blood flow; PSBF, posterior subendocardial blood flow; PTBF, posterior transmural blood flow; Endo/Epi ratio, ratio between subendocardial and subepicardial blood flow; ME; STE. * P Ͻ 0.05 vs. control; † P Ͻ 0.05 vs. 1 h; ‡ P Ͻ 0.05 vs. 4 h; §P Ͻ 0.05 vs. ME.
Infarct size and inflammation. Infarct size was 6.5 Ϯ 4.5% of the area at risk in the ME group and 3.4 Ϯ 3.2% in the STE group (not significant). In the STE group, myocardial infarction was confined to the subendocardial layer of the apex in only three of six dogs. The 42-m embolizing microspheres were more or less homogeneously distributed throughout the area at risk (Endo/Epi 1.24 Ϯ 0.17), and there was a patchy, transmurally more or less homogeneous distribution (Endo/ Epi 1.22 Ϯ 1.18) of multiple, small necrotic foci (area 0.255 Ϯ 0.227 mm 2 ) throughout the ischemic region of all hearts in the ME group (Fig. 2A) . There was no infarction in the control areas in both groups. There was a significantly more pronounced inflammatory response in the microembolized myocardium (Fig. 2, B and C) both versus the intraindividual remote myocardium and the poststenotic myocardium in the STE group (Fig. 3A and B) . 
DISCUSSION
The present study confirms perfusion-contraction matching with acute coronary inflow restriction but demonstrates a progressive loss of regional myocardial function with no detectable decrease in RMBF after coronary microembolization, i.e., perfusion-contraction mismatch (Fig. 1) .
The slightly preferential deposition of the 42-m spheres to the subendocardium which has been previously demonstrated (28) was reflected by the transmural distribution of microinfarcts. The 42-m spheres were chemically inert, as demonstrated in the in vitro chemotaxis assay. Also, infiltrating leukocytes were apparent around and within the microinfarcts, but not adherent to or surrounding the 42-m spheres.
In previous studies, coronary microembolization has acutely depressed regional myocardial function in proportion to the number of embolizing particles in anesthetized dogs (16, 17) , and it has elicited a sustained, adenosine-mediated (17) increase in coronary inflow, reflecting reactive hyperemia of adjacent myocardium. In the present study, microembolization induced a progressive reduction in regional function without a measurable decrease in regional flow or even a hemodilution-associated (hemoglobin from 12.7 Ϯ 1.5 at control to 9.8 Ϯ 1.7 g/dl at 8 h) increase in flow after 8 h. A decrease of blood flow in microregions supplied by embolized microvessels was probably counterbalanced by reactive hyperemia in adjacent regions, but could not be detected in the present study with blood flow measurement limited to a spatial resolution of about 300 mg of tissue (20) .
The total area of necrosis resulting from microembolization in the present study was probably too small to account for the progressive dysfunction. However, the mechanical disadvantage from multiple ischemic and subsequently necrotic foci may be greater than that from a compact ischemic, subsequently necrotic area of the same size, due to a largely greater border zone and tethering of normal to ischemic areas (12) . Alternatively, the infiltration of leukocytes in the microembolized myocardium that has been previously observed in pigs (1) suggests a role of inflammatory mediators such as TNF-␣ (1, 9, 18, 29) and/or free radicals (16) in inducing the cardiodepressive response. An inflammatory process as the cause of the observed dysfunction is also supported by its progressive nature. The specific cytokines and mediators involved and the potential recovery from the inflammatory response will have to be determined in future studies.
Coronary microembolization occurs clinically secondary to spontaneous or therapeutic plaque rupture (2, 4-7, 24, 26) . The frequently observed myocardial dysfunction that persists after reperfusion in these scenarios may indeed be related to microembolization, such as observed microscopically at autopsy (7), and an associated inflammatory response. The inflammatory response to inert microspheres in the present heparinized preparation (10) certainly underestimates the response to true atherosclerotic plaque material with its thrombogenic, vasoconstrictor, and inflammatory potential. Recently, a prognostic impact of the inflammatory mediators TNF-␣ and interleukin-6 in patients with unstable angina has been shown (3), further emphasizing the role of microembolization and inflammation in acute coronary syndromes and their sequelae. Fig. 3 . Number of polymorphonuclear leukocytes (A) and macrophages/monocytes (B) in the area at risk and the control area. Values are means Ϯ SD. The number of cells infiltrating the area at risk in the ME group was significantly greater than that in the STE group and that of the control area.
